To test whether the patient antibodies can recognize endogenously expressed Env, we used the T47D breast cancer cell line, which is known to upregulate HERV-K102 but not K108 [46,47], after treatment with female steroid hormones [42]. This evidence concerns the gene ERVW-1 and breast carcinoma.